EVRYSDI
Drug timelines are a Plus or Pro feature.
18 regulatory and trial events tracked for EVRYSDI, covering 2020-08-07 to 2026-04-21. Get the full timeline:
Most recent: EMA Authorised: Evrysdi (risdiplam) — Roche Registration GmbH
18 regulatory and trial events tracked for EVRYSDI, covering 2020-08-07 to 2026-04-21. Get the full timeline:
Most recent: EMA Authorised: Evrysdi (risdiplam) — Roche Registration GmbH